|
2M7W
Independently verified structure of gp41-M-MAT, a membrane associated MPER trimer from HIV-1 gp41
Deposited 2013-05-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–59(59 aa)
Chain B
1–59(59 aa)
Chain C
1–59(59 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6;303 K;Pressure ambient
NMR sample composition
2 mM protein, 50 mM sodium phosphate, 100 mM [U-99% 2H] DPC, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
5KWW
Crystal Structure of Inhibitor JNJ-53718678 In Complex with Prefusion RSV F Glycoprotein
Deposited 2016-07-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain F
1–28(28 aa)
Fragment:F0 (UNP residues 1-513) + Envelope glycoprotein (UNP residues 1-28)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
NHE 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID × 3
SO4 SULFATE ION × 30
6YA 3-[[5-chloranyl-1-(3-methylsulfonylpropyl)indol-2-yl]methyl]-1-[2,2,2-tris(fluoranyl)ethyl]imidazo[4,5-c]pyridin-2-one × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 9.5;293 K;1.54 M potassium/sodium tartrate, 0.2 M lithium sulfate, 0.1 M CHES, pH 9.5
|
Resolution 2.50 Å
R-free 0.239
|
|
5U68
Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus
Deposited 2016-12-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–28(28 aa)
Fragment:UNP P03420 residues 1-513,UNP M1E1E4 residues 1-28
Chain B
1–28(28 aa)
Fragment:UNP P03420 residues 1-513,UNP M1E1E4 residues 1-28
Chain C
1–28(28 aa)
Fragment:UNP P03420 residues 1-513,UNP M1E1E4 residues 1-28
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;295 K;0.1M Potassium Nitrate, 0.1M Citrate Phosphate pH 4.2, 1 % Tacsimate pH 7.0, 14 (w/v) % PEG 6000
|
Resolution 3.08 Å
R-free 0.239
|
|
6A0Z
Crystal structure of broadly neutralizing antibody 13D4 bound to H5N1 influenza hemagglutinin, HA head region
Deposited 2018-06-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–28(28 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;289.15 K;0.1 M Bis-Tris-propane pH 6.5, 0.2 M NaAc and 18% (w/v) PEG 3350
|
Resolution 2.33 Å
R-free 0.218
|
|
6APD
Crystal structure of RSV F bound by AM22 and the infant antibody ADI-19425
Deposited 2017-08-17
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 15
PDB declaration: pentadecameric
|
Chain A
1–29(29 aa)
Chain B
1–29(29 aa)
Chain C
1–29(29 aa)
|
Mutation:N67I, P129A, S215P, I379V, M447V,N67I, P129A, S215P, I379V, M447V,N67I, P129A, S215P, I379V, M447V,N67I, P129A, S215P, I379V, M447V
Mutation:N67I, P129A, S215P, I379V, M447V,N67I, P129A, S215P, I379V, M447V,N67I, P129A, S215P, I379V, M447V,N67I, P129A, S215P, I379V, M447V
Mutation:N67I, P129A, S215P, I379V, M447V,N67I, P129A, S215P, I379V, M447V,N67I, P129A, S215P, I379V, M447V,N67I, P129A, S215P, I379V, M447V
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;10% PEG 4000
10% 2-propanol
0.1 M sodium citrate pH 5.5
|
Resolution 4.10 Å
R-free 0.256
|
|
6CNV
INFLUENZA B/BRISBANE HEMAGGLUTININ FAB CR9115 SD84H COMPLEX
Deposited 2018-03-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 15
PDB declaration: pentadecameric
|
Chain B
1–28(28 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.5;295 K;100 mM sodium acetate, pH 4.5, 5.5 M sodium formate, and 5% MPD
|
Resolution 4.10 Å
R-free 0.276
|
|
6CXC
3.9A Cryo-EM structure of murine antibody bound at a novel epitope of respiratory syncytial virus fusion protein
Deposited 2018-04-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain A
1–30(30 aa)
Chain B
1–30(30 aa)
Chain C
1–30(30 aa)
Chain D
1–30(30 aa)
Chain E
1–30(30 aa)
Chain F
1–30(30 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen NITROGEN
|
Resolution 3.90 Å
|
|
6DC3
RSV prefusion F bound to RSD5 Fab
Deposited 2018-05-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain F
1–28(28 aa)
|
Not recorded
|
SO4 SULFATE ION × 13
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;1.8 M Lithium sulfate, 0.1 M Tris pH 8.0
|
Resolution 3.50 Å
R-free 0.205
|
|
6DC5
RSV prefusion F in complex with AM22 Fab
Deposited 2018-05-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–28(28 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
CD CADMIUM ION × 1
PEG DI(HYDROXYETHYL)ETHER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;32% PEG 400, 4% PEG 3350, 0.01 M cadmium chloride, 0.1 M sodium acetate pH 5.5
|
Resolution 3.50 Å
R-free 0.280
|
|
6DC5
RSV prefusion F in complex with AM22 Fab
Deposited 2018-05-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain D
1–28(28 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
CD CADMIUM ION × 1
PEG DI(HYDROXYETHYL)ETHER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;32% PEG 400, 4% PEG 3350, 0.01 M cadmium chloride, 0.1 M sodium acetate pH 5.5
|
Resolution 3.50 Å
R-free 0.280
|
|
6DC5
RSV prefusion F in complex with AM22 Fab
Deposited 2018-05-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain G
1–28(28 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
CD CADMIUM ION × 1
PEG DI(HYDROXYETHYL)ETHER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;32% PEG 400, 4% PEG 3350, 0.01 M cadmium chloride, 0.1 M sodium acetate pH 5.5
|
Resolution 3.50 Å
R-free 0.280
|
|
6G9I
Crystal structure of Ebolavirus glycoprotein in complex with clomipramine
Deposited 2018-04-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain B
2–28(27 aa)
|
Mutation:H613A,H613A,H613A,H613A
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12
GOL GLYCEROL × 12
CXX 3-(3-CHLORO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N,N-DIMETHYLPROPAN-1-AMINE × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.2;293 K;9% (w/v) PEG 6000 and 0.1 M Sodium citrate tribasic dihydrate
|
Resolution 2.19 Å
R-free 0.208
|
|
6ONA
Crystal structure of Influenza hemagglutinin from strain A/Hickox/JY2/1940
Deposited 2019-04-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–28(28 aa)
Fragment:UNP residues 18-509
Chain B
1–28(28 aa)
Fragment:UNP residues 18-509
Chain C
1–28(28 aa)
Fragment:UNP residues 18-509
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 11
PEG DI(HYDROXYETHYL)ETHER × 7
CL CHLORIDE ION × 7
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;287 K;0.1 uL 9.5 mg/mL SEC-purified InvbQ.18715.a.KN11.PD38349 in 2 5 mM Tris, pH 8.5, 150 mM sodium chloride + 0.1 uL mother liquor (0.1 M sodium citrate, pH 5.5, 0.1 M magnesium chloride, 34% PEG400), flash-frozen, crystal ID 308018c7 data set les6-6
|
Resolution 1.95 Å
R-free 0.230
|
|
6OUS
Structure of fusion glycoprotein from human respiratory syncytial virus
Deposited 2019-05-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain B
1–28(28 aa)
Chain D
1–28(28 aa)
Chain F
1–28(28 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;100 mM Tris 8.5, 10% PEG 8000, 200 mM ammonium sulfate
|
Resolution 3.40 Å
R-free 0.275
|
|
6OUS
Structure of fusion glycoprotein from human respiratory syncytial virus
Deposited 2019-05-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain H
1–28(28 aa)
Chain J
1–28(28 aa)
Chain L
1–28(28 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;100 mM Tris 8.5, 10% PEG 8000, 200 mM ammonium sulfate
|
Resolution 3.40 Å
R-free 0.275
|
|
6VKC
Crystal Structure of Inhibitor JNJ-36811054 in Complex with Prefusion RSV F Glycoprotein
Deposited 2020-01-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain F
1–28(28 aa)
|
Not recorded
|
CL CHLORIDE ION × 3
SO4 SULFATE ION × 18
R0J 3-{[5-chloro-1-(4,4,4-trifluorobutyl)-1H-imidazo[4,5-b]pyridin-2-yl]methyl}-1-cyclopropyl-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one × 3
TAR D(-)-TARTARIC ACID × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;1.52M K/Na tartrate, 0.2M LiSO4, 0.1M CHES pH 9.5
|
Resolution 2.60 Å
R-free 0.229
|
|
6VKD
Crystal Structure of Inhibitor JNJ-36689282 in Complex with Prefusion RSV F Glycoprotein
Deposited 2020-01-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain F
1–28(28 aa)
|
Not recorded
|
R0P 1-cyclopropyl-3-({1-[3-(methylsulfonyl)propyl]-1H-pyrrolo[3,2-c]pyridin-2-yl}methyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one × 3
CL CHLORIDE ION × 3
SO4 SULFATE ION × 18
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;1.64M K/Na tartrate, 0.2M LiSO4, 0.1M CHES pH 9.5
|
Resolution 2.50 Å
R-free 0.229
|
|
6VKE
Crystal Structure of Inhibitor JNJ-40012665 in Complex with Prefusion RSV F Glycoprotein
Deposited 2020-01-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain F
1–28(28 aa)
|
Not recorded
|
NHE 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID × 3
R0S 4-(5-chloro-2-{[1-(3,4-dimethoxyphenyl)-2-oxo-1,2-dihydro-3H-imidazo[4,5-c]pyridin-3-yl]methyl}-1H-indol-1-yl)butanenitrile × 3
CL CHLORIDE ION × 6
SO4 SULFATE ION × 12
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;1.64M K/Na tartrate, 0.2M LiSO4, 0.1M CHES pH 9.5
|
Resolution 2.10 Å
R-free 0.199
|
|
6W16
Crystal structure of a human metapneumovirus monomeric fusion protein complexed with 458 Fab
Deposited 2020-03-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain F
1–28(28 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;298 K;0.5 M Ammonium sulfate, 0.1 M Sodium citrate tribasic dihydrate pH 5.6, 1.0 M Lithium sulfate monohydrate
|
Resolution 3.10 Å
R-free 0.234
|
|
7AD1
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(One up trimer)
Deposited 2020-09-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–28(28 aa)
Chain B
1–28(28 aa)
Chain C
1–28(28 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 10
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.92 Å
|
|
7FJN
Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with two T6 Fab
Deposited 2021-08-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain A
1–28(28 aa)
Chain B
1–28(28 aa)
Chain C
1–28(28 aa)
|
Mutation:R682G,R683S,R685S,K968P,V969P,S305T
Mutation:R682G,R683S,R685S,K968P,V969P,S305T
Mutation:R682G,R683S,R685S,K968P,V969P,S305T
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 25
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.25 Å
|
|
7KC1
Cryo-EM structure of SRR2899884.46167H+MEDI8852L fab in complex with Victoria HA
Deposited 2020-10-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain B
1–28(28 aa)
Chain D
1–28(28 aa)
Chain I
1–28(28 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 15
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.41 Å
|
|
7L7F
Cryo-EM structure of human ACE2 receptor bound to protein encoded by vaccine candidate BNT162b1
Deposited 2020-12-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain E
1–28(28 aa)
Chain F
1–28(28 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.24 Å
|
|
7QTI
SARS-CoV-2 S Omicron Spike B.1.1.529 - 3-P2G3 and 1-P5C3 Fabs (Global)
Deposited 2022-01-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 11
PDB declaration: undecameric
|
Chain A
1–30(30 aa)
Chain D
1–30(30 aa)
Chain K
1–30(30 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 26
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;PBS
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.04 Å
|
|
7ZRV
cryo-EM structure of omicron spike in complex with de novo designed binder, full map
Deposited 2022-05-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain A
1–30(30 aa)
Chain B
1–30(30 aa)
Chain C
1–30(30 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 16
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.80 Å
|
|
8HFX
Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with white-tailed deer ACE2
Deposited 2022-11-13
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–29(29 aa)
Chain B
1–29(29 aa)
Chain C
1–29(29 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 31
ZN ZINC ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.98 Å
|
|
9BJM
Crystal Structure of Inhibitor 5c in Complex with Prefusion RSV F Glycoprotein
Deposited 2024-04-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–28(28 aa)
|
Not recorded
|
A1APZ 1'-{[5-chloro-1-(4,4,4-trifluorobutyl)-1H-1,3-benzimidazol-2-yl]methyl}-1-(methanesulfonyl)spiro[azetidine-3,3'-indol]-2'(1'H)-one × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;3M NaFormate
|
Resolution 2.07 Å
R-free 0.203
|